J. Seoane
Molecular Biology · Cancer Discovery · 2001–2017
A researcher in the Science corpus: 9 papers; trusts 8 researchers and is trusted by 6 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 103 citations into it; #5,910 of 17,773 by trust here, #3,514 by citations
- Oncology — 95 citations into it; #1,356 of 1,698 by trust here, #673 by citations
- Pathology and Forensic Medicine — 20 citations into it
Whom J. Seoane trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts J. Seoane overall
- J. Massagué
- A. Hata
- E. Batlle
- D. Accili
- Ying E. Zhang
- A. Moustakas
- Ye-Guang Chen
- K. Arden
- D. Muñoz‐Espín
- Scott W. Lowe
Papers from J. Seoane's perspective
Ordered by how strongly the researchers J. Seoane trusts endorse each paper. Same corpus, a different order for every researcher.
- Signal Transduction by the TGF-β Superfamily (Science)
- Structural Basis of Heteromeric Smad Protein Assembly in TGF-β Signaling
- Regulation of the Polarity Protein Par6 by TGFß Receptors Controls Epithelial Cell Plasticity (Science)
- Role of tissue stroma in cancer cell invasion (Journal of Pathology)
- Live or let die: the cell's response to p53 (Nature Reviews. Cancer)
- Surfing the p53 network (Nature)
- Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. (Cell)
- G1 cell-cycle control and cancer (Nature)
- TGF-β signaling in tumor suppression and cancer progression (Nature Genetics)
- Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. (Cell)
Their papers
- Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. (2004) — 1,088 citations
- Repression of p15INK4b expression by Myc through association with Miz-1 (2001) — 627 citations
- Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage (2002) — 395 citations
- Smad transcription factors. (2005) — 2,527 citations
- TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma. (2010) — 619 citations
- Interrogating open issues in cancer precision medicine with patient-derived xenografts (2017) — 601 citations
- Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets (2015) — 932 citations
- Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma (2015) — 753 citations
- Patient Derived Xenograft Models: An Emerging Platform for Translational Cancer Research (2014) — 1,525 citations